Medimaging Integrated Solution Inc. (6796.TW)
TWD 84.0
(0.24%)
TWD 84.0
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 168.42 Million | 112.79 Million | 45.95 Million | 55.81 Million | -13.32 Million |
| Net Income | 92.98 Million | 87.41 Million | 80.9 Million | 60.23 Million | 4.78 Million |
| Depreciation & Amortization | 31.63 Million | 30.06 Million | 33 Million | 28.87 Million | 27.2 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 2.95 Million | 495 Thousand | 664 Thousand | 377 Thousand | 383 Thousand |
| Change in working capital | 53.29 Million | 15.57 Million | -55.54 Million | -35.16 Million | -32.15 Million |
| Other non-cash items | -1.69 Million | -47 Thousand | 669 Thousand | 583 Thousand | -13.54 Million |
| Investing Cash Flow | -328.68 Million | -102.63 Million | -19.82 Million | -47.8 Million | -43.44 Million |
| Investments in PPE | -199.33 Million | -50.74 Million | -30.82 Million | -41.5 Million | -33.59 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -125.28 Million | -60.31 Million | -15.88 Million | -7.22 Million | - |
| Sales/Maturities of investments | - | 10 Million | 26.71 Million | 330 Thousand | - |
| Other Investing Activities | -4.05 Million | -1.57 Million | 177 Thousand | 395 Thousand | -9.85 Million |
| Financing Cash Flow | 359.8 Million | 40.35 Million | 23.69 Million | 33.57 Million | -13.45 Million |
| Debt repayment | -316.34 Million | -48.81 Million | -3.11 Million | -38.92 Million | -7.71 Million |
| Dividends payments | -59.8 Million | -53.19 Million | -36.02 Million | -4.49 Million | -46.94 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 105.8 Million | 144.16 Million | 65 Million | 1.6 Million | - |
| Other Financing Activities | 55 Thousand | 12 Thousand | - | - | 41.2 Million |
| Accounts receivables | 20.02 Million | - | - | - | -11.51 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | 3.26 Million | -18.19 Million | -32.22 Million | -6.57 Million | -18.99 Million |
| Other working capital | 30 Million | - | - | - | -1.64 Million |
| Cash at beginning of period | 275.11 Million | 224.26 Million | 174.46 Million | 132.9 Million | 203.98 Million |
| Cash at end of period | 474.33 Million | 275.11 Million | 224.26 Million | 174.46 Million | 132.9 Million |
| Capital Expenditure | -199.33 Million | -50.74 Million | -30.82 Million | -41.5 Million | -33.59 Million |
| Effect of forex changes on cash | -319 Thousand | 331 Thousand | -19 Thousand | -27 Thousand | -860 Thousand |
| Net cash flow / Change in cash | 199.22 Million | 50.85 Million | 49.79 Million | 41.56 Million | -71.08 Million |
| Free Cash Flow | -30.91 Million | 62.05 Million | 15.12 Million | 14.31 Million | -46.92 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.46 Million | -12.06 Million | 92.98 Million | 20.69 Million | 21.19 Million | 34.1 Million |
| Depreciation & Amortization | 13.99 Million | 13.35 Million | 31.63 Million | 8.48 Million | 8.25 Million | 7.55 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 26 Thousand | 43 Thousand | 2.95 Million | 44 Thousand | 2.75 Million | 68 Thousand |
| Change in working capital | -29.46 Million | 25.28 Million | 53.29 Million | 120.69 Million | -6.57 Million | -45.21 Million |
| Other non-cash items | -344 Thousand | 651 Thousand | -1.69 Million | -1.62 Million | 737 Thousand | -894 Thousand |
| Investing Cash Flow | 68.57 Million | -118.92 Million | -328.68 Million | -203.85 Million | -84.49 Million | -48.55 Million |
| Investments in PPE | -50.83 Million | -46.3 Million | -199.33 Million | -40.26 Million | -88.4 Million | -48.89 Million |
| Acquisitions | -2 Million | -52.64 Million | - | - | - | - |
| Investment purchases | 583 Thousand | -40.58 Million | -125.28 Million | -125.28 Million | - | - |
| Sales/Maturities of investments | 121.23 Million | 21 Million | - | -38.84 Million | 8.84 Million | - |
| Other Investing Activities | -411 Thousand | -396 Thousand | -4.05 Million | 537 Thousand | -4.93 Million | - |
| Financing Cash Flow | -11.83 Million | 7.49 Million | 359.8 Million | 22.56 Million | 274.41 Million | 47.92 Million |
| Debt repayment | -11.63 Million | -9.03 Million | -316.34 Million | -23.41 Million | -230.09 Million | -47.41 Million |
| Dividends payments | - | - | -59.8 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.38 Million | - | 105.8 Million | - | 104.54 Million | 1.14 Million |
| Other Financing Activities | 1.38 Million | 20 Thousand | 55 Thousand | 12 Thousand | 51 Thousand | - |
| Accounts receivables | -24.74 Million | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 1.67 Million | 5.4 Million | 3.26 Million | 3.83 Million | -11.89 Million | 11.32 Million |
| Other working capital | 5.28 Million | - | - | - | - | - |
| Cash at beginning of period | 391.08 Million | 474.33 Million | 275.11 Million | 505.47 Million | 297.25 Million | 307.35 Million |
| Cash at end of period | 422.71 Million | 391.08 Million | 474.33 Million | 474.33 Million | 505.47 Million | 297.25 Million |
| Capital Expenditure | -50.83 Million | -46.3 Million | -199.33 Million | -40.26 Million | -88.4 Million | -48.89 Million |
| Effect of forex changes on cash | 147 Thousand | 295 Thousand | -319 Thousand | -340 Thousand | 522 Thousand | -617 Thousand |
| Net cash flow / Change in cash | 31.63 Million | -83.25 Million | 199.22 Million | -31.14 Million | 208.22 Million | -10.09 Million |
| Free Cash Flow | -76.07 Million | -18.41 Million | -30.91 Million | 110.22 Million | -70.63 Million | -57.73 Million |
SPAGO
PIXY
VIVA
0QQR
SEEK
BMIN4